Project Details
Description
MT2016-10 :A Phase 2a, Dose-Escalation, Open-Label Study to Evaluate the Safety, Tolerability, and Activity of KD025 in Subjects with Chronic Graft Versus Host Disease
| Status | Finished |
|---|---|
| Effective start/end date | 4/20/16 → 10/31/22 |
Funding
- KADMON CORPORATION, LLC
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.